Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
- PMID: 32173483
- DOI: 10.1016/j.annonc.2020.02.016
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
Keywords: Clinical Practice Guidelines; cancer-related fatigue; diagnosis; treatment.
Conflict of interest statement
Disclosure AF has reported advisory boards and/or honoraria for presentations for Roche, Pfizer, Lilly and Celgene; KJ has reported advisory boards and/or honoraria for presentations for Merck Sharp & Dohme, Merck, Amgen, Hexal, Reimser, Helsinn, Tesaro, Kreussler, Voluntis, Pzifer, Pomme-Med, PharmaMar, Prime Oncology and Onko Update; CIR has reported collaborations with Inpharm, Kyowa Kirin, Amgen Europe and Molteni Spa; RB, FR, SF, JW, MG and MVH have declared no potential conflicts of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical